Novotech Health Holdings Pte, a clinical research and testing provider backed by private equity firm TPG and Singapore sovereign wealth fund GIC Pte, swung back into profit in 2022 after posting higher revenues.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
